369 related articles for article (PubMed ID: 27296521)
1. Induced pluripotent stem cells in the inherited cardiomyopathies: From disease mechanisms to novel therapies.
Ross SB; Fraser ST; Semsarian C
Trends Cardiovasc Med; 2016 Nov; 26(8):663-672. PubMed ID: 27296521
[TBL] [Abstract][Full Text] [Related]
2. Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes.
Eschenhagen T; Mummery C; Knollmann BC
Cardiovasc Res; 2015 Apr; 105(4):424-38. PubMed ID: 25618410
[TBL] [Abstract][Full Text] [Related]
3. Novel Desmin Mutation p.Glu401Asp Impairs Filament Formation, Disrupts Cell Membrane Integrity, and Causes Severe Arrhythmogenic Left Ventricular Cardiomyopathy/Dysplasia.
Bermúdez-Jiménez FJ; Carriel V; Brodehl A; Alaminos M; Campos A; Schirmer I; Milting H; Abril BÁ; Álvarez M; López-Fernández S; García-Giustiniani D; Monserrat L; Tercedor L; Jiménez-Jáimez J
Circulation; 2018 Apr; 137(15):1595-1610. PubMed ID: 29212896
[TBL] [Abstract][Full Text] [Related]
4. Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies.
Kamdar F; Klaassen Kamdar A; Koyano-Nakagawa N; Garry MG; Garry DJ
J Card Fail; 2015 Sep; 21(9):761-70. PubMed ID: 25934595
[TBL] [Abstract][Full Text] [Related]
5. Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic Cardiomyopathies.
Brodehl A; Ebbinghaus H; Deutsch MA; Gummert J; Gärtner A; Ratnavadivel S; Milting H
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31489928
[TBL] [Abstract][Full Text] [Related]
6. Untangling the Biology of Genetic Cardiomyopathies with Pluripotent Stem Cell Disease Models.
Buikema JW; Wu SM
Curr Cardiol Rep; 2017 Apr; 19(4):30. PubMed ID: 28315121
[TBL] [Abstract][Full Text] [Related]
7. Human-induced pluripotent stem cells for modelling metabolic perturbations and impaired bioenergetics underlying cardiomyopathies.
Ramachandra CJA; Chua J; Cong S; Kp MMJ; Shim W; Wu JC; Hausenloy DJ
Cardiovasc Res; 2021 Feb; 117(3):694-711. PubMed ID: 32365198
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic recapitulation and correction of desmoglein-2-deficient cardiomyopathy using human-induced pluripotent stem cell-derived cardiomyocytes.
Shiba M; Higo S; Kondo T; Li J; Liu L; Ikeda Y; Kohama Y; Kameda S; Tabata T; Inoue H; Nakamura S; Takeda M; Ito E; Takashima S; Miyagawa S; Sawa Y; Hikoso S; Sakata Y
Hum Mol Genet; 2021 Jul; 30(15):1384-1397. PubMed ID: 33949662
[TBL] [Abstract][Full Text] [Related]
9. Modeling of human cardiomyopathy with induced pluripotent stem cells.
Lee YK; Ng KM; Tse HF
J Biomed Nanotechnol; 2014 Oct; 10(10):2562-85. PubMed ID: 25992409
[TBL] [Abstract][Full Text] [Related]
10. From Hypertrophy to Heart Failure: What Is New in Genetic Cardiomyopathies.
Reza N; Musunuru K; Owens AT
Curr Heart Fail Rep; 2019 Oct; 16(5):157-167. PubMed ID: 31243690
[TBL] [Abstract][Full Text] [Related]
11. Disease Modeling and Disease Gene Discovery in Cardiomyopathies: A Molecular Study of Induced Pluripotent Stem Cell Generated Cardiomyocytes.
Kumar S; Curran JE; Kumar K; DeLeon E; Leandro AC; Peralta J; Williams-Blangero S; Blangero J
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805011
[TBL] [Abstract][Full Text] [Related]
12. Maturation status of sarcomere structure and function in human iPSC-derived cardiac myocytes.
Bedada FB; Wheelwright M; Metzger JM
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1829-38. PubMed ID: 26578113
[TBL] [Abstract][Full Text] [Related]
13. The role of mutations in the SCN5A gene in cardiomyopathies.
Zaklyazminskaya E; Dzemeshkevich S
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1799-805. PubMed ID: 26916278
[TBL] [Abstract][Full Text] [Related]
14. Pluripotent stem cell-derived cardiomyocytes for treatment of cardiomyopathic damage: Current concepts and future directions.
Garbern JC; Escalante GO; Lee RT
Trends Cardiovasc Med; 2021 Feb; 31(2):85-90. PubMed ID: 31983535
[TBL] [Abstract][Full Text] [Related]
15. Potential Strategies for Clinical Translation of Repeated Cell Therapy.
Vrtovec B; Bolli R
Circ Res; 2019 Mar; 124(5):690-692. PubMed ID: 30817255
[TBL] [Abstract][Full Text] [Related]
16. Human-induced pluripotent stem cell models of inherited cardiomyopathies.
Karakikes I; Termglinchan V; Wu JC
Curr Opin Cardiol; 2014 May; 29(3):214-9. PubMed ID: 24576884
[TBL] [Abstract][Full Text] [Related]
17. Maturation-Based Model of Arrhythmogenic Right Ventricular Dysplasia Using Patient-Specific Induced Pluripotent Stem Cells.
Wen JY; Wei CY; Shah K; Wong J; Wang C; Chen HS
Circ J; 2015; 79(7):1402-8. PubMed ID: 25971409
[TBL] [Abstract][Full Text] [Related]
18. Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications.
Yoshida Y; Yamanaka S
Circ Res; 2017 Jun; 120(12):1958-1968. PubMed ID: 28596174
[TBL] [Abstract][Full Text] [Related]
19. Modelling inherited cardiac disease using human induced pluripotent stem cell-derived cardiomyocytes: progress, pitfalls, and potential.
van Mil A; Balk GM; Neef K; Buikema JW; Asselbergs FW; Wu SM; Doevendans PA; Sluijter JPG
Cardiovasc Res; 2018 Dec; 114(14):1828-1842. PubMed ID: 30169602
[TBL] [Abstract][Full Text] [Related]
20. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
